Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• Vitamin K antagonists like warfarin are crucial for preventing blood clots after heart valve surgery.
• A common clinical observation is a reduced warfarin sensitivity post-surgery, complicating anticoagulation management.
• This study aimed to validate this observation and inform the development of improved warfarin dosing strategies.

Purpose of the Study:

• To investigate the changes in warfarin sensitivity and requirements in patients following heart valve surgery.
• To compare warfarin dosing and efficacy in post-valve surgery patients versus those treated for atrial fibrillation.
• To gather data for creating a predictive dosing algorithm for this patient population.

Main Methods:

• Retrospective analysis of 200 patients on warfarin (target INR 2.0-3.0) within three months post-heart valve surgery.
• Collected data on warfarin dosage, International Normalized Ratio (INR) results, and calculated time in therapeutic range (TTR).
• Included a control group of patients initiated on warfarin for atrial fibrillation.

Main Results:

• Patients undergoing heart valve surgery showed a progressive increase in warfarin requirements over three months (mean dose increased by 26%).
• Mean INR decreased from 2.5 to 2.1 in the post-surgery group, indicating reduced sensitivity.
• Time in therapeutic range (TTR) was 48.5%, with 40.8% of readings below the therapeutic INR of 2.0, unlike stable controls.

Conclusions:

• A significant decrease in warfarin sensitivity occurs in the initial months after heart valve surgery, leading to subtherapeutic anticoagulation.
• A novel dosing algorithm accounting for these increased warfarin needs has been developed.
• Prospective validation of this proposed algorithm is necessary to confirm its efficacy.